News

Jack Antonoff Celebrated as 2025 ASCAP Songwriter of the Year

Jack Antonoff Celebrated as 2025 ASCAP Songwriter of the Year

Jack Antonoff Shines at the ASCAP Pop Music Awards

Acclaimed songwriter and producer Jack Antonoff has officially added another prestigious accolade to his impressive collection: the ASCAP Pop Music Songwriter of the Year. This significant recognition honors his remarkable contributions to the pop music landscape, showcasing his work with top-charting artists.

'Lose Control' Named Song of the Year

The standout track 'Lose Control' was awarded the ASCAP Pop Music Song of the Year. A collaboration with the talented songwriter Joshua "Ammo" Coleman and the breakthrough artist Teddy Swims, this track has made waves, dominating the charts throughout the past year. It set the remarkable record of being the longest-running song in the Billboard Hot 100 top 10, staying charted for an impressive 58 weeks.

Sony Music Publishing Honored as Publisher of the Year

This year, Sony Music Publishing received honors as the ASCAP Pop Music Publisher of the Year, reflecting its exceptional role in shaping the pop music industry. The publisher has been behind several significant hits, including those by artists like Beyoncé, Dua Lipa, and Noah Kahan. Their contributions to modern pop music have proved invaluable, producing chart-toppers and memorable tunes.

Celebrating More Songwriters and Achievements

Numerous other songwriters were celebrated in the 2025 ASCAP Pop Music Awards, highlighting the diverse talents shaping today's music scene. Notable winners included Amy Allen, who penned tracks like 'Espresso' and 'Feather'; Justin Tranter with works like 'Good Luck, Babe!'; and Olivia Rodrigo whose lyrical prowess continues to capture global audiences. This assembly of talent gathered to honor each other's contributions to the art of songwriting, reinforcing the collaborative nature of music creation.

As the only U.S. performing rights organization governed by music creators, ASCAP puts the spotlight on the invaluable work of songwriters and publishers. They gather data to determine the top-performing songs based on radio plays and streaming statistics, ensuring that the rightful creators receive recognition and royalties for their efforts.

The glamorous celebration took place at an exclusive event, where attendees mingled alongside industry leaders, reflecting on the previous year’s musical successes and looking forward to future collaborations. The atmosphere buzzed with creativity and respect for the hard work that goes into crafting pop music.

About ASCAP

The American Society of Composers, Authors and Publishers (ASCAP) serves over one million members, including songwriters, composers, and music publishers. Founded by music creators, ASCAP operates as a not-for-profit organization, licensing an extensive repertoire of over 20 million musical works for various businesses, from streaming platforms to retail establishments.

ASCAP's mission is centered on advocating for the rights of music creators, working diligently to ensure they are compensated fairly for their art. They maintain a vital role in the music industry, pushing for innovation while providing resources and community support for creators to thrive in their careers.

Frequently Asked Questions

Who is Jack Antonoff?

Jack Antonoff is a renowned songwriter and producer known for his innovative music collaborations and production work with various top artists.

What song won the 2025 ASCAP Pop Music Song of the Year?

'Lose Control', co-written by Jack Antonoff and Ammo, won this prestigious award at the event.

Which organization recognizes pop music achievements?

The American Society of Composers, Authors and Publishers (ASCAP) honors songwriters and publishers in the music industry.

Who were the other notable award winners this year?

Other winners included Amy Allen, Dua Lipa, and Beyoncé, showcasing a diverse range of talent in the pop music scene.

What is the significance of the ASCAP Pop Music Awards?

The awards celebrate the achievements of songwriters and publishers, recognizing their impact on the music industry through data-driven performances.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

BioVid Debuts AI to Mimic Physician Decision-Making

Updated Category News Views 47

Revolutionizing Understanding: BioVid Mimetics™ Now here's something that's shaking the research tree: BioVid's launching Mimetics™, and it's a big deal. They've come up with AI that can mirror how physicians think and decide. This ain't your run-of-the-mill tech stuff—it's groundbreaking in understanding physician decision-making. The Core: How Do Doctors Really...

Continue Reading
Lilly's Sofe-M Shakes Up Ovarian Cancer Treatment

Updated Category News Views 111

Ovarian Cancer Treatment Sees a New Challenger Alright, folks, Eli Lilly (NYSE:LLY) is stepping up with their latest findings in ovarian cancer treatment, and it's got plenty of people in a buzz. They've dropped new data for their investigational drug, Sofetabart mipitecan, or 'Sofe-M' for short, which targets this unrelenting disease with a punch that’s hard to ignore....

Continue Reading
AZ Health Workers Step Up for Community Wellness

Updated Category News Views 4

Health Screenings: A Step Before the Hospital Sometimes it's the basics, like a plain old health screening, that can shift the tides from crisis to care. That's exactly where AZ Blue Health Choice and Zeihan ProHealth come into the picture, aiming to pin those health concerns before they spiral out of control. For your average Arizonan who finds healthcare as elusive as a...

Continue Reading
Enigmata Innovates AI Security with Finovifi Tie-Up

Updated Category News Views 94

Emerging AI Risks and Protective Measures AI in financial spaces is like walking a tightrope, there's potential but caution is crucial. Enter Enigmata, diving headfirst into this arena by shaking hands with the Finovifi Marketplace. Their aim? To bolster AI's promise without letting sensitive data slip through the cracks. Sentinel: A New Guard for Sensitive Data Let's not...

Continue Reading
Podcast Giants Converge in Tennessee for POD U Summit

Updated Category News Views 57

Nashville Becomes a Hotspot for Podcasters Amidst the strumming guitars and honky-tonk vibes of Nashville, Tennessee transformed into the epicenter of podcasting innovation thanks to Rebel Audio's inaugural summit, POD U. Here we had big names like Mike 'Big Mike' Majlak rubbing shoulders with sports experts and media moguls—a true concoction of voices shaping the...

Continue Reading
Home Insurance Gaps: Risky Assumptions Uncovered

Updated Category News Views 53

Unseen Threats to Homeownership Safety Liability gaps in insurance are like those stubborn stains on the carpet you keep missing—nearly invisible until you're flat on your face. In Alpharetta and Fulton County, homes aren't as secure from financial pitfalls as their charming façades suggest. So, what's the danger that folks are glossing over here? Hidden Dangers of...

Continue Reading
Americas Cardroom Smashes Prize Pools; Bahamas Up Next

Updated Category News Views 49

Ah, poker. Where dreams are won with a flick of the wrist and a well-placed bluff. This week, it was all eyes on Americas Cardroom’s Dual Venom PKOs, and let me tell you, they didn't just meet expectations—they chewed them up and spat them out like yesterday's jam. Two Titans Crowned in Poker Showdown The action wrapped up with a jaw-dropping $6,862,500 prize pool....

Continue Reading
Honeywell Aerospace Faces Class Action: Deadline Looms

Updated Category News Views 37

Navigating the Legal Storm with Honeywell Look, investors never have it easy, and when lawsuits start flying like today's news about Honeywell Aerospace, you better have your wits about you. Now here comes Kahn Swick & Foti, LLC, ringing the alarm bells. Any holders of Honeywell Aerospace stocks between late June and early September of '26 are squarely in the spotlight....

Continue Reading
Savvy Moves: Avoiding Pitfalls When Buying Used Vans

Updated Category News Views 14

When you're eyeing a used work van, don't just kick the tires and jot down the mileage—there's a whole backyard BBQ checklist you need to chew through. Tony Collichio, the work van guru from Spencerport, lays it down for us, highlighting key questions to ask before pulling out the checkbook. And let me tell you, these aren’t your everyday 'how does it drive?' queries....

Continue Reading
Abbott's Oncodetect Test: Game-Changer for Cancer Recurrence

Updated Category News Views 4

Pioneering Progress in Colorectal Cancer Detection There's a new player in the world of cancer diagnostics, and it's setting a fresh standard. Abbott's Oncodetect test, featured at the ESMO Congress, has shown a profound leap in sensitivity—30 percent over the older whole-exome sequencing approach. For those doing the math on the stock charts, Abbott (NYSE: ABT) is...

Continue Reading

Top 5 Most Recently Viewed Articles

Clare Locke Advocates for Megan Thee Stallion in Defamation Case

Updated Category News Views 111

Clare Locke LLP Champions Megan Thee Stallion's Defamation Case Clare Locke LLP, a respected name in defamation law, has taken a bold step to support Megan Thee Stallion's pursuit of justice against Milagro Cooper. The firm has filed a motion for leave to present an amicus brief that specifically endorses Megan's effort to have a jury's defamation ruling reinstated. This...

Continue Reading
Bankers Signal Looming Economic Challenges Amid Uncertainty

Updated Category News Views 167

Bankers Signal Looming Economic Challenges Amid Uncertainty Interest rate fluctuations, credit quality, and tariffs are significant concerns for financial institutions. A recent survey highlights the anxiety among bankers regarding the economic climate and impending recession. Survey Highlights Economic Fears According to a survey from fintech IntraFi, which gathered...

Continue Reading
Dave Portnoy Questions Elon Musk Amid Tesla's Plummeting Stock

Updated Category News Views 162

Tesla's Stock Dilemma: Portnoy's Concerns Tesla’s stock, designated as TSLA, has recently experienced a significant decline, stirring up discussions among investors and enthusiasts alike. Dave Portnoy, the founder of Barstool Sports, has voiced his frustration regarding this situation, bringing forth some pointed questions about Elon Musk’s priorities. In a recent...

Continue Reading
Akropolis Group's Credit Rating Affirmed Amid Strategic Changes

Updated Category News Views 88

Akropolis Group’s Robust Credit Rating Amid Strategic Reassessments Renowned international credit rating agency S&P Global Ratings recently evaluated the financial outlook for Akropolis Group, a prominent player in the real estate development and management sector. This assessment took into account significant structural governance changes within the Vilniaus Prekyba...

Continue Reading
Arcutis Takes a Significant Step with ZORYVE Cream for Kids

Updated Category News Views 156

Arcutis Advances ZORYVE® Cream for Pediatric Use Arcutis Biotherapeutics, Inc. is making headlines with its recent submission of a supplemental New Drug Application (sNDA) aimed at expanding the use of ZORYVE (roflumilast) cream 0.3% to treat plaque psoriasis in children as young as 2 years old. If approved, ZORYVE would be the first topical PDE4 inhibitor specifically...

Continue Reading